Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.700
+0.070 (4.29%)
At close: Apr 15, 2026, 4:00 PM EDT
1.710
+0.010 (0.59%)
After-hours: Apr 15, 2026, 7:49 PM EDT

Cardiff Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1161922896663252
Market Cap Growth
-46.91%-33.52%336.64%5.71%-75.20%-61.88%
Enterprise Value
58.75133.74197.78-7.24-40.68113.95
Last Close Price
1.702.814.341.481.406.01
PE Ratio
--4.07-4.57-1.59-1.57-8.23
PS Ratio
195.99323.67422.72135.50162.04702.52
PB Ratio
2.564.233.480.950.591.80
P/TBV Ratio
2.504.142.490.950.571.67
P/FCF Ratio
--5.06-7.64-2.10-1.80-10.85
P/OCF Ratio
--5.06-7.66-2.14-1.85-10.95
EV/Sales Ratio
99.07225.52289.58-14.84-105.39317.41
EV/EBITDA Ratio
--2.75-4.100.161.03-4.01
EV/EBIT Ratio
--2.73-4.070.161.02-3.95
EV/FCF Ratio
--3.52-5.240.231.17-4.90
Debt / Equity Ratio
0.000.000.010.020.020.02
Debt / EBITDA Ratio
-0.02-0.02-0.03-0.05-0.07-0.11
Debt / FCF Ratio
-0.02-0.02-0.04-0.07-0.08-0.13
Net Debt / Equity Ratio
-1.27-1.27-1.09-1.04-0.96-0.98
Net Debt / EBITDA Ratio
1.181.181.871.612.594.85
Net Debt / FCF Ratio
1.511.512.392.312.955.92
Asset Turnover
0.010.010.010.000.000.00
Quick Ratio
3.573.576.897.1913.5821.55
Current Ratio
3.673.677.087.4114.2522.28
Return on Equity (ROE)
-71.45%-71.45%-59.51%-47.07%-31.37%-21.07%
Return on Assets (ROA)
-61.56%-61.56%-54.41%-45.91%-30.03%-20.30%
Return on Invested Capital (ROIC)
505.84%505.84%953.10%-10610.30%-1218.75%-4487.56%
Return on Capital Employed (ROCE)
-75.76%-75.76%-62.79%-50.58%-31.75%-21.25%
Earnings Yield
-39.47%-24.56%-21.89%-62.84%-63.57%-12.15%
FCF Yield
-32.67%-19.78%-13.08%-47.59%-55.68%-9.22%
Buyback Yield / Dilution
-40.27%-40.27%-6.65%-2.47%-11.71%-86.97%
Total Shareholder Return
-40.27%-40.27%-6.65%-2.47%-11.71%-86.97%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q